Back to top

Goldman Sachs Sticks to Their Buy Rating for AstraZeneca (AZN)

Goldman Sachs analyst Rajan Sharma maintained a Buy rating on AstraZeneca yesterday and set a price target of p16,300.00. The company’s shares clos...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AstraZeneca PLC (AZN)